Logo image of ENGN

ENGENE HOLDINGS INC (ENGN) Stock Price, Quote, News and Overview

NASDAQ:ENGN - Nasdaq - CA29286M1059 - Common Stock - Currency: USD

4.2  +0.29 (+7.42%)

After market: 4.01 -0.19 (-4.52%)

ENGN Quote, Performance and Key Statistics

ENGENE HOLDINGS INC

NASDAQ:ENGN (5/20/2025, 8:00:01 PM)

After market: 4.01 -0.19 (-4.52%)

4.2

+0.29 (+7.42%)

Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology
Statistics
52 Week High12.8
52 Week Low2.65
Market Cap214.12M
Shares50.98M
Float0
Yearly DividendN/A
Dividend YieldN/A
PEN/A
Fwd PEN/A
Earnings (Next)06-11 2025-06-11
IPO12-10 2021-12-10


ENGN short term performance overview.The bars show the price performance of ENGN in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 20 -20 40 -40

ENGN long term performance overview.The bars show the price performance of ENGN in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60

The current stock price of ENGN is 4.2 USD. In the past month the price increased by 5%. In the past year, price decreased by -67.34%.

ENGENE HOLDINGS INC / ENGN Daily stock chart

ENGN Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 18 327.00B
AMGN AMGEN INC 13.25 147.86B
GILD GILEAD SCIENCES INC 14.1 135.84B
VRTX VERTEX PHARMACEUTICALS INC N/A 114.96B
REGN REGENERON PHARMACEUTICALS 13.87 66.38B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 37.94B
ARGX ARGENX SE - ADR 98.52 35.31B
ONC BEIGENE LTD-ADR 5.89 25.53B
BNTX BIONTECH SE-ADR N/A 24.45B
NTRA NATERA INC N/A 21.01B
BIIB BIOGEN INC 8.25 19.13B
SMMT SUMMIT THERAPEUTICS INC N/A 18.11B

About ENGN

Company Profile

ENGN logo image enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. The company is headquartered in Saint-Laurent, Quebec and currently employs 56 full-time employees. The company went IPO on 2021-12-10. The Company’s lead program is detalimogene voraplasmid, (detalimogene) for patients with non-muscle invasive bladder cancer (NMIBC), a disease with a high clinical burden. Detalimogene is being evaluated in the ongoing multi-cohort LEGEND Phase II study, which includes a cohort studying detalimogene in Bacillus Calmette-Guerin (BCG)-unresponsive patients with carcinoma in situ (Cis). Detalimogene is being developed through its proprietary Dually Derivatized Oligochitosan (DDX) platform, which enables penetration of mucosal tissues and delivery of a wide range of sizes and types of cargo, including DNA and various forms of RNA. The firm is developing non-viral genetic medicines based on its DDX gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Company Info

ENGENE HOLDINGS INC

4868 Rue Levy, Suite 220

Saint-Laurent QUEBEC CA

Employees: 32

ENGN Company Website

ENGN Investor Relations

Phone: 15143324888

ENGENE HOLDINGS INC / ENGN FAQ

What is the stock price of ENGENE HOLDINGS INC today?

The current stock price of ENGN is 4.2 USD. The price increased by 7.42% in the last trading session.


What is the ticker symbol for ENGENE HOLDINGS INC stock?

The exchange symbol of ENGENE HOLDINGS INC is ENGN and it is listed on the Nasdaq exchange.


On which exchange is ENGN stock listed?

ENGN stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for ENGENE HOLDINGS INC stock?

17 analysts have analysed ENGN and the average price target is 24.48 USD. This implies a price increase of 482.86% is expected in the next year compared to the current price of 4.2. Check the ENGENE HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is ENGENE HOLDINGS INC worth?

ENGENE HOLDINGS INC (ENGN) has a market capitalization of 214.12M USD. This makes ENGN a Micro Cap stock.


How many employees does ENGENE HOLDINGS INC have?

ENGENE HOLDINGS INC (ENGN) currently has 32 employees.


What are the support and resistance levels for ENGENE HOLDINGS INC (ENGN) stock?

ENGENE HOLDINGS INC (ENGN) has a resistance level at 4.2. Check the full technical report for a detailed analysis of ENGN support and resistance levels.


Should I buy ENGENE HOLDINGS INC (ENGN) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does ENGENE HOLDINGS INC (ENGN) stock pay dividends?

ENGN does not pay a dividend.


When does ENGENE HOLDINGS INC (ENGN) report earnings?

ENGENE HOLDINGS INC (ENGN) will report earnings on 2025-06-11.


What is the Price/Earnings (PE) ratio of ENGENE HOLDINGS INC (ENGN)?

ENGENE HOLDINGS INC (ENGN) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.52).


ENGN Technical Analysis

ChartMill assigns a technical rating of 1 / 10 to ENGN. When comparing the yearly performance of all stocks, ENGN is a bad performer in the overall market: 94.61% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

ENGN Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to ENGN. While ENGN seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ENGN Financial Highlights

Over the last trailing twelve months ENGN reported a non-GAAP Earnings per Share(EPS) of -1.52. The EPS decreased by -118.2% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -24.15%
ROE -27.62%
Debt/Equity 0.09
Chartmill High Growth Momentum
EPS Q2Q%-4.59%
Sales Q2Q%N/A
EPS 1Y (TTM)-118.2%
Revenue 1Y (TTM)N/A

ENGN Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 85% to ENGN. The Buy consensus is the average rating of analysts ratings from 17 analysts.


Ownership
Inst OwnersN/A
Ins OwnersN/A
Short Float %N/A
Short Ratio1.55
Analysts
Analysts84.71
Price Target24.48 (482.86%)
EPS Next Y-39.02%
Revenue Next YearN/A